UNIVERSITA DEGLI STUDI DI MILANO

Their core work

The University of Milan is one of Italy's largest research universities, with deep strength in life sciences, neuroscience, and computational biology. Their H2020 portfolio reveals a powerhouse in biomedical research — from epigenetics and stem cell biology to neurodegenerative disease mechanisms and drug delivery systems. They also maintain significant capacity in food safety, agricultural genomics, and data-intensive science including AI and high-performance computing. Beyond bench science, they are active in science communication, public engagement, and research infrastructure governance across Europe.

What they specialise in

How they've shifted over time

In 2015–2018, the university's H2020 work centered on computational neuroscience (brain simulation, neuroinformatics, HPC, neuromorphic computing) and fundamental life sciences (stem cells, epigenetics, biomarkers). From 2019 onward, the focus shifted markedly toward artificial intelligence and machine learning applications, research infrastructure governance (FAIR principles, open science), and sustainability-oriented research including neurodegeneration therapeutics and in vitro methods. The evolution reflects a move from basic science toward translational, data-driven, and policy-relevant research.

Moving decisively toward AI-powered biomedical research and FAIR/open science infrastructure — a strong partner for data-intensive health and life science consortia forming now.

How they like to work

With 63 coordinated projects (33% of their portfolio), UMIL is a confident consortium leader comfortable managing large EU projects, though they participate as partners even more frequently (115 projects). Their 1,515 unique partners across 64 countries make them one of the most networked universities in H2020 — a true hub rather than a loyal-to-few organization. This breadth means they bring an extensive contact book to any consortium and are experienced at integrating into diverse teams.

An exceptionally well-connected institution with 1,515 unique consortium partners spanning 64 countries — covering virtually all of Europe and extending well into global partnerships. Their network density suggests they are a go-to partner for Italian and Southern European consortium building.

What sets them apart

UMIL sits at the intersection of life sciences and computational methods in a way few Italian universities match — combining wet-lab expertise in epigenetics, stem cells, and neuroscience with growing AI and data science capacity. Their unusually high coordination rate (33%) for a university of this size shows they don't just contribute expertise but drive research agendas. For consortium builders, they offer a rare combination: deep domain science, proven project management, and one of the largest partner networks in H2020.

Highlights from their portfolio

• SEMICOMPLEX
  Coordinated with EUR 1.9M — their largest single grant, running 7 years on computational molecular dynamics for spectroscopy, showing deep commitment to computational methods.
• ESCUDO-CLOUD
  Coordinated a focused digital security project (EUR 849K) on cloud data ownership — demonstrates breadth beyond their life science core into cybersecurity.
• MOGLYNET
  Coordinated EUR 1M training network linking metabolic science (glycolysis) to cardiovascular disease — exemplifies their strength in translational biomedical research.